Form 8-K - Current report:
SEC Accession No. 0001193125-11-315665
Filing Date
2011-11-17
Accepted
2011-11-17 16:11:55
Documents
4
Period of Report
2011-11-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d257477d8k.htm 8-K 14942
2 PRESS RELEASE DATED NOVEMBER 16, 2011 d257477dex991.htm EX-99.1 12685
3 GRAPHIC g257477g32r27.jpg GRAPHIC 3603
4 GRAPHIC g257477g82h53.jpg GRAPHIC 30647
  Complete submission text file 0001193125-11-315665.txt   76400
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 111213183
SIC: 2835 In Vitro & In Vivo Diagnostic Substances